These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6128867)

  • 1. Prenalterol in the treatment of congestive heart failure developing during beta-blocking therapy. A comparison with frusemide in patients with acute myocardial infarction.
    Dahlström U; Karlsson E
    Acta Med Scand; 1982; 212(3):125-30. PubMed ID: 6128867
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic trial of sequential treatment with diuretic, vasodilator, and positive inotropic drugs in left ventricular failure following acute myocardial infarction.
    Nelson GI; Silke B; Ahuja RC; Walker C; Forsyth DR; Verma SP; Taylor SH
    Am Heart J; 1984 Jun; 107(6):1202-9. PubMed ID: 6144266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
    Hutton I; Tweddel AC; Bastian BC; Murray RG
    Acta Med Scand Suppl; 1981; 652():163-8. PubMed ID: 6120615
    [No Abstract]   [Full Text] [Related]  

  • 4. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.
    Glover DR; Wathen CG; Murray RG; Petch MC; Muir AL; Littler WA
    Br Heart J; 1985 Feb; 53(2):208-15. PubMed ID: 2857088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of Prenalterol on left ventricular function of coronary patients].
    Javernaro A; Bolognesi R; Giacometti P; Potenza D; Cortesi G; Cucchini F
    Acta Biomed Ateneo Parmense; 1983; 54(1):17-8. PubMed ID: 6134412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hemodynamic actions of prenalterol in left ventricular failure.
    Awan NA; Evenson MK; Needham KE; Mason DT
    Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of prenaterol and cardiac glycosides in patients with recent myocardial infarction.
    Boström PA; Andersson J; Johansson BW; Lilja B; Thorell J; Tidfält K; Westerling S
    Eur J Clin Invest; 1984 Jun; 14(3):175-80. PubMed ID: 6147253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short and long-term effects of hydralazine and combined hydralazine and prenalterol therapy in patients with congestive heart failure.
    Drexler H; Löllgen H; Just H
    Acta Med Scand Suppl; 1982; 659():315-24. PubMed ID: 6127898
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic and cardiometabolic effects of prenalterol in patients with acute myocardial infarction and shock.
    Reiz S; Friedman A; Häggmark S
    Acta Anaesthesiol Scand; 1981 Jun; 25(3):235-9. PubMed ID: 6119869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy.
    Erbel R; Meyer J; Lambertz H; Schweizer P; Voelker W; Krebs W; Braun G; Effert S
    Circulation; 1982 Aug; 66(2):361-9. PubMed ID: 6124326
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro studies on the cardiac activity of prenalterol with reference to use in congestive heart failure.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1982 Jan; 220(1):77-85. PubMed ID: 6118432
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term effect of a new beta-agonist prenalterol in patients with severe congestive heart failure (author's transl)].
    Lambertz H; Erbel R; Meyer J; Schweizer P; Effert S
    Z Kardiol; 1982 Jan; 71(2):65-74. PubMed ID: 6122313
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.
    Tweddel AC; Murray RG; Pearson D; Martin W; Hutton I
    Br Heart J; 1982 Apr; 47(4):375-80. PubMed ID: 6121566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experiences with prenalterol as an antidote to Beta-adrenoceptor blockade.
    Kulling P
    Acta Med Scand Suppl; 1982; 659():191-9. PubMed ID: 6127889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenalterol in symptomatic sinus node dysfunction.
    Feleke E; Rydén L; Smedgård P; Westerling S
    Am Heart J; 1985 Jan; 109(1):185-7. PubMed ID: 2857060
    [No Abstract]   [Full Text] [Related]  

  • 16. Prenalterol as long-term therapy for chronic congestive heart failure. A randomized cross-over trial.
    Dahlström U; Areskog M; Wranne B; Karlsson E
    Acta Med Scand; 1984; 216(2):199-207. PubMed ID: 6149671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic effects of intravenously administered prenalterol in patients with severe heart failure.
    Waagstein F; Estrada-Yamamoto M; Reiz S; Reyes C; Hjalmarson A
    Acta Med Scand Suppl; 1982; 659():221-31. PubMed ID: 6127891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.
    Weiss A; Pfister B; Imhof P; Degen PH; Burckhardt D; Dubach UC
    Eur J Clin Pharmacol; 1980 Nov; 18(5):383-90. PubMed ID: 6108221
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of prenalterol administered orally in patients with congestive heart failure.
    Hjalmarson A; Abelardo N; Caidahl K; Reyes C; Waagstein F; Wallentin I; Wikstrand J; Estrada-Yamamoto M
    Acta Med Scand Suppl; 1982; 659():201-20. PubMed ID: 6127890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of heart failure with beta adrenoceptor agonists].
    Klein G; Wirtzfeld A; Schnelle K
    MMW Munch Med Wochenschr; 1983 Apr; 125(14):277-80. PubMed ID: 6134232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.